相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nose-to-brain drug delivery for the treatment of Alzheimer's disease: current advancements and challenges
A. Prabakaran et al.
EXPERT OPINION ON DRUG DELIVERY (2022)
Effect of curcumin nanoparticles on streptozotocin-induced male Wistar rat model of Alzheimer's disease
Neveen A. Noor et al.
METABOLIC BRAIN DISEASE (2022)
Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease
Johant Lakey-Beitia et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
Neurotoxicity of metal-containing nanoparticles and implications in glial cells
Xiaoru Chang et al.
JOURNAL OF APPLIED TOXICOLOGY (2021)
Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease
Amy F. T. Arnsten et al.
ALZHEIMERS & DEMENTIA (2021)
Design and Validation of Liposomal ApoE2 Gene Delivery System to Evade Blood-Brain Barrier for Effective Treatment of Alzheimer's Disease
Sanjay Arora et al.
MOLECULAR PHARMACEUTICS (2021)
Synaptic basis of Alzheimer's disease: Focus on synaptic amyloid beta, P-tau and mitochondria
Albin John et al.
AGEING RESEARCH REVIEWS (2021)
Angiopep-2 modi fi ed lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB
Jingjing Zhu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Determination of β-amyloid oligomer using electrochemiluminescent aptasensor with signal enhancement by AuNP/MOF nanocomposite
Lixiu Yin et al.
MICROCHIMICA ACTA (2021)
Cholesterol-lowering drugs reduce APP processing to Aβ by inducing APP dimerization
Vanessa F. Langness et al.
MOLECULAR BIOLOGY OF THE CELL (2021)
Liposome Enhanced Detection of Amyloid Protein Aggregates
Istvan Kocsis et al.
ORGANIC LETTERS (2021)
Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies
Liang Han et al.
ACTA PHARMACEUTICA SINICA B (2021)
Focused Ultrasound and Microbubbles-Mediated Drug Delivery to Brain Tumor
Sheng-Kai Wu et al.
PHARMACEUTICS (2021)
ApoE-Targeting Increases the Transfer of Solid Lipid Nanoparticles with Donepezil Cargo across a Culture Model of the Blood-Brain Barrier
Gizem Ruya Topal et al.
PHARMACEUTICS (2021)
Intranasal drug delivery for treatment of Alzheimer's disease
Leonor C. Fonseca et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2021)
Large Amino Acid Mimicking Selenium-Doped Carbon Quantum Dots for Multi-Target Therapy of Alzheimer's Disease
Xi Zhou et al.
FRONTIERS IN PHARMACOLOGY (2021)
Transgene distribution and immune response after ultrasound delivery of rAAV9 and PHP.B to the brain in a mouse model of amyloidosis
Rikke Hahn Kofoed et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
Advances in developing therapeutic strategies for Alzheimer's disease
Thuy Trang Nguyen et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood-Brain Barrier by Using Different Transport Mechanisms
Jisu Song et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Role of metals in Alzheimer's disease
Nikita Das et al.
METABOLIC BRAIN DISEASE (2021)
Tacrine Induces Endoplasmic Reticulum-Stressed Apoptosis via Disrupting the Proper Assembly of Oligomeric Acetylcholin- esterase in Cultured Neuronal Cells (vol 100, pg 456, 2021)
E. Y. L. Liu et al.
MOLECULAR PHARMACOLOGY (2021)
Cholesterol and Alzheimer's Disease; From Risk Genes to Pathological Effects
Femke M. Feringa et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Alzheimer's disease drug development pipeline: 2021
Jeffrey Cummings et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2021)
Development of immunotherapy and nanoparticles-based strategies for the treatment of Parkinson's disease
Ramesh Duwa et al.
JOURNAL OF PHARMACEUTICAL INVESTIGATION (2021)
2021 Alzheimer's disease facts and figures
[Anonymous]
ALZHEIMERS & DEMENTIA (2021)
Dendrimer-tesaglitazar conjugate induces a phenotype shift of microglia and enhances β-amyloid phagocytosis
Louis DeRidder et al.
NANOSCALE (2021)
Copper Ion Uptake by Chitosan in the Presence of Amyloid-β and Histidine
Cynthia R. A. Mahl et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2020)
Alzheimer's Disease Targeted Nano-Based Drug Delivery Systems
Gulcem Altinoglu et al.
CURRENT DRUG TARGETS (2020)
Gold Nanoparticles Treatment Reverses Brain Damage in Alzheimer's Disease Model
Natalia dos Santos Tramontin et al.
MOLECULAR NEUROBIOLOGY (2020)
Near-Infrared Light-Powered Janus Nanomotor Significantly Facilitates Inhibition of Amyloid-β Fibrillogenesis
Wei Liu et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Targeting Tau Hyperphosphorylation via Kinase Inhibition: Strategy to Address Alzheimer's Disease
Ahmad Abu Turab Naqvi et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Nanoemulsions for targeting the neurodegenerative diseases: Alzheimer's, Parkinson's and Prion's
Prabhuti Nirale et al.
LIFE SCIENCES (2020)
Hierarchical Porous Carbon-PLLA and PLGA Hybrid Nanoparticles for Intranasal Delivery of Galantamine for Alzheimer's Disease Therapy
Stavroula G. Nanaki et al.
PHARMACEUTICS (2020)
Intelligently thermoresponsive flower-like hollow nano-ruthenium system for sustained release of nerve growth factor to inhibit hyperphosphorylation of tau and neuronal damage for the treatment of Alzheimer's disease
Hui Zhou et al.
BIOMATERIALS (2020)
Neuronal mitochondria-targeted micelles relieving oxidative stress for delayed progression of Alzheimer's disease
Peng Yang et al.
BIOMATERIALS (2020)
Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease
R. G. R. Pinheiro et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Memantine nanoemulsion: a new approach to treat Alzheimer's disease
Atinderpal Kaur et al.
JOURNAL OF MICROENCAPSULATION (2020)
Metformin loaded phosphatidylserine nanoliposomes improve memory deficit and reduce neuroinflammation in streptozotocin-induced Alzheimer's disease model
Partow Mirzaee Saffari et al.
LIFE SCIENCES (2020)
Treatment of Alzheimer's diseases using donepezil nanoemulsion: an intranasal approach
Atinderpal Kaur et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)
Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders
Salman Ul Islam et al.
MOLECULES (2020)
Current understanding of metal ions in the pathogenesis of Alzheimer's disease
Lu Wang et al.
TRANSLATIONAL NEURODEGENERATION (2020)
Nontoxic Black Phosphorus Quantum Dots Inhibit Insulin Amyloid Fibrillation at an Ultralow Concentration
Siqi Wang et al.
ISCIENCE (2020)
An electrochemical immunosensor using gold nanoparticles-PAMAM-nanostructured screen-printed carbon electrodes for tau protein determination in plasma and brain tissues from Alzheimer patients
Claudia A. Razzino et al.
BIOSENSORS & BIOELECTRONICS (2020)
Magnetic nanoemulsions as candidates for Alzheimer's disease dual imaging theranostics
Orestis Antonoglou et al.
NANOTECHNOLOGY (2020)
Targeting nanoparticles to the brain by exploiting the blood-brain barrier impermeability to selectively label the brain endothelium
Daniel Gonzalez-Carter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Progress of RAGE Molecular Imaging in Alzheimer's Disease
Yanyan Kong et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology
Aleksandra Zielinska et al.
MOLECULES (2020)
Use of Biodegradable, Chitosan-Based Nanoparticles in the Treatment of Alzheimer's Disease
Eniko Manek et al.
MOLECULES (2020)
Membrane Transporters and Their Regulatory Mechanisms at the Brain and Retinal Barriers to Establish Therapies for Refractory Central Nervous System Diseases
Shin-ichi Akanuma
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2020)
Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer's disease
Ke Hou et al.
NATURE COMMUNICATIONS (2020)
Mechanisms of Pathogenic Tau and A beta Protein Spreading in Alzheimer's Disease
Paolo d'Errico et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Advances in microphysiological blood-brain barrier (BBB) models towards drug delivery
Caleb S. Lee et al.
CURRENT OPINION IN BIOTECHNOLOGY (2020)
Clitoria ternatea Mediated Synthesis of Graphene Quantum Dots for the Treatment of Alzheimer's Disease
Kajal Tak et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Inhibition and disaggregation of amyloid β protein fibrils through conjugated polymer-core thermoresponsive micelles
Hao Geng et al.
JOURNAL OF MATERIALS CHEMISTRY B (2020)
Brain Delivery of Nanomedicines: Trojan Horse Liposomes for Plasmid DNA Gene Therapy of the Brain
William M. Pardridge
FRONTIERS IN MEDICAL TECHNOLOGY (2020)
Self- assembled lactoferrin-conjugated linoleic acid micelles as an orally active targeted nanoplatform for Alzheimer's disease
Mona M. Agwa et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Nanoliposomes as a Therapeutic Tool for Alzheimer's Disease
Lara Ordonez-Gutierrez et al.
FRONTIERS IN SYNAPTIC NEUROSCIENCE (2020)
Multifunctional magnetite nanoparticles to enable delivery of siRNA for the potential treatment of Alzheimer's
Natalia Lopez-Barbosa et al.
DRUG DELIVERY (2020)
Diphtheria toxoid nanoparticles improve learning and memory impairment in animal model of Alzheimer's disease
Samane Heydari et al.
PHARMACOLOGICAL REPORTS (2020)
Microbubbles in combination with focused ultrasound for the delivery of quercetin-modified sulfur nanoparticles through the blood brain barrier into the brain parenchyma and relief of endoplasmic reticulum stress to treat Alzheimer's disease
Yanan Liu et al.
NANOSCALE (2020)
PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model
Neta Rosenzweig et al.
NATURE COMMUNICATIONS (2019)
Codelivery of Plasmid and Curcumin with Mesoporous Silica Nanoparticles for Promoting Neurite Outgrowth
Cheng-Shun Cheng et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Impact of Gold Nanoparticles on Amyloid β-Induced Alzheimer's Disease in a Rat Animal Model: Involvement of STIM Proteins
Mehdi Sanati et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil
I. T. Mendes et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
Amanda Cano et al.
JOURNAL OF CONTROLLED RELEASE (2019)
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
John V. Pluvinage et al.
NATURE (2019)
Improving Sensitivity and Specificity of Amyloid-β Peptides and Tau Protein Detection with Antibiofouling Magnetic Nanoparticles for Liquid Biopsy of Alzheimer's Disease
Yuancheng Li et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2019)
A tyrosinase-induced fluorescence immunoassay for detection of tau protein using dopamine-functionalized CuInS2/ZnS quantum dots
Li Chen et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2019)
Optimization and characterization of rivastigmine nanolipid carrier loaded transdermal patches for the treatment of dementia
Meenakshi Kanwar Chauhan et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2019)
Theories of Aging and the Prevalence of Alzheimer's Disease
Kaynara Trevisan et al.
BIOMED RESEARCH INTERNATIONAL (2019)
PECAM-1 Stabilizes Blood-Brain Barrier Integrity and Favors Paracellular T-Cell Diapedesis Across the Blood-Brain Barrier During Neuroinflammation
Isabella Wimmer et al.
FRONTIERS IN IMMUNOLOGY (2019)
Lactoferrin Coupled Lower Generation PAMAM Dendrimers for Brain Targeted Delivery of Memantine in Aluminum-Chloride-Induced Alzheimer's Disease in Mice
Avinash Gothwal et al.
BIOCONJUGATE CHEMISTRY (2019)
Nanomedicine for the Treatment of Alzheimer's Disease
Beatrice Formicola et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2019)
The neuropathological diagnosis of Alzheimer's disease
Michael A. DeTure et al.
MOLECULAR NEURODEGENERATION (2019)
The role of zinc, copper, manganese and iron in neurodegenerative diseases
Leda Mezzaroba et al.
NEUROTOXICOLOGY (2019)
CLVFFA-Functionalized Gold Nanoclusters Inhibit Aβ40 Fibrillation, Fibrils' Prolongation, and Mature Fibrils' Disaggregation
Sijia Hao et al.
ACS CHEMICAL NEUROSCIENCE (2019)
The Optimization Design Of Lactoferrin Loaded HupA Nanoemulsion For Targeted Drug Transport Via Intranasal Route
Yueyao Jiang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
L-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia
Johanna Huttunen et al.
SCIENTIFIC REPORTS (2019)
Fate of nanoparticles in the central nervous system after intrathecal injection in healthy mice
K. T. Householder et al.
SCIENTIFIC REPORTS (2019)
Review of Current Strategies for Delivering Alzheimer's Disease Drugs across the Blood-Brain Barrier
Ka Hong Wong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Improvement of memory deficits in the rat model of Alzheimer's disease by erythropoietin-loaded solid lipid nanoparticles
Tahereh Dara et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2019)
Microenvironment Remodeling Micelles for Alzheimer's Disease Therapy by Early Modulation of Activated Microglia
Yifei Lu et al.
ADVANCED SCIENCE (2019)
Chemicals used for the induction of Alzheimer's disease-like cognitive dysfunctions in rodents
Onesimus Mahdi et al.
BIOMEDICAL RESEARCH AND THERAPY (2019)
Risk factors for Alzheimer's disease
Richard A. Armstrong
FOLIA NEUROPATHOLOGICA (2019)
Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-β burden in several amyloid transgenic mouse models
Martine Latta-Mahieu et al.
GLIA (2018)
Microglia in Alzheimer's disease
David V. Hansen et al.
JOURNAL OF CELL BIOLOGY (2018)
Curcumin-graphene quantum dots for dual mode sensing platform: Electrochemical and fluorescence detection of APOe4, responsible of Alzheimer's disease
Abdelmoneim Mars et al.
ANALYTICA CHIMICA ACTA (2018)
The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
Harald Hampel et al.
BRAIN (2018)
Role of Blood-Brain Barrier in Alzheimer's Disease
Zhiyou Cai et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid- clearance in human astrocytes
Lauren K. Fong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
A nanoformulation for the preferential accumulation in adult neurogenic niches
Catarina Praca et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Crossing the blood-brain barrier with nanoparticles
Yiqun Zhou et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Dependence of Nanoparticle Toxicity on Their Physical and Chemical Properties
Alyona Sukhanova et al.
NANOSCALE RESEARCH LETTERS (2018)
Resveratrol loaded solid lipid nanoparticles attenuate mitochondrial oxidative stress in vascular dementia by activating Nrf2/HO-1 pathway
Aarti Yadav et al.
NEUROCHEMISTRY INTERNATIONAL (2018)
Dependence of Nanoparticle Toxicity on Their Physical and Chemical Properties
Alyona Sukhanova et al.
NANOSCALE RESEARCH LETTERS (2018)
Oxidative stress and the amyloid beta peptide in Alzheimer's disease
C. Cheignon et al.
REDOX BIOLOGY (2018)
PD-1 deficiency is not sufficient to induce myeloid mobilization to the brain or alter the inflammatory profile during chronic neurodegeneration
J. Obst et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer's disease
Shengnuo Fan et al.
DRUG DELIVERY (2018)
PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer's disease: in vitro and in vivo studies
Marcelle Silva-Abreu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Using superparamagnetic iron oxide nanoparticles to enhance bioavailability of quercetin in the intact rat brain
Rezvan Enteshari Najafabadi et al.
BMC PHARMACOLOGY & TOXICOLOGY (2018)
Nicotinamide loaded functionalized solid lipid nanoparticles improves cognition in Alzheimer's disease animal model by reducing Tau hyperphosphorylation
Molood Alsadat Vakilinezhad et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Blood-Brain Delivery Methods Using Nanotechnology
Daniel Mihai Teleanu et al.
PHARMACEUTICS (2018)
Nano carriers for drug transport across the blood-brain barrier
Xinming Li et al.
JOURNAL OF DRUG TARGETING (2017)
Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro
Ipek Baysal et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Cerebral Hypoperfusion and Glucose Hypometabolism: Key Pathophysiological Modulators Promote Neurodegeneration, Cognitive Impairment, and Alzheimer's Disease
Mak Adam Daulatzai
JOURNAL OF NEUROSCIENCE RESEARCH (2017)
Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015
Dev Mehta et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease
Yu Yamazaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Cortical Iron Reflects Severity of Alzheimer's Disease
Sara van Duijn et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Microglia in Alzheimer's disease
Heela Sarlus et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer's Disease
Joana A. Loureiro et al.
MOLECULES (2017)
Can immunotherapy treat neurodegeneration?
Michal Schwartz
SCIENCE (2017)
Nanoparticles as potential clinical therapeutic agents in Alzheimer's disease: focus on selenium nanoparticles
Mustafa Naziroglu et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2017)
Role of RAGE in Alzheimer's Disease
Zhiyou Cai et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2016)
Galantamine-loaded solid-lipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations
Shubham Misra et al.
DRUG DELIVERY (2016)
Peptide/protein vaccine delivery system based on PLGA particles
Mojgan Allahyari et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Ionizing radiation-engineered nanogels as insulin nanocarriers for the development of a new strategy for the treatment of Alzheimer's disease
Pasquale Picone et al.
BIOMATERIALS (2016)
Role of tau in the spatial organization of axonal microtubules: keeping parallel microtubules evenly distributed despite macromolecular crowding
Alix Mephon-Gaspard et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer's disease
Dongdong Sun et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Progress in drug development for Alzheimer's disease: An overview in relation to mitochondria energy metabolism
Jana Hroudova et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease
Eameema Muntimadugu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery
Shital Lungare et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease
Kuti Baruch et al.
NATURE MEDICINE (2016)
Nose to brain delivery of astaxanthin-loaded solid lipid nanoparticles: fabrication, radio labeling, optimization and biological studies
Prakash Chandra Bhatt et al.
RSC ADVANCES (2016)
Physical Principles of Nanoparticle Cellular Endocytosis
Sulin Zhang et al.
ACS NANO (2015)
Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease
Tiantian Yin et al.
ACTA BIOMATERIALIA (2015)
Cu2+ accentuates distinct misfolding of Aβ(1-40) and Aβ(1-42) peptides, and potentiates membrane disruption
Christian J. Matheou et al.
BIOCHEMICAL JOURNAL (2015)
A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease
Fanfei Meng et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Dual ligand immunoliposomes for drug delivery to the brain
Joana A. Loureiro et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: Effect on formulation and characterization parameters
Brijesh Shah et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Focused ultrasound-mediated drug delivery through the blood-brain barrier
Alison Burgess et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease
Maarten Rotman et al.
JOURNAL OF CONTROLLED RELEASE (2015)
AGE AND LESION-INDUCED INCREASES OF GDNF TRANSGENE EXPRESSION IN BRAIN FOLLOWING INTRACEREBRAL INJECTIONS OF DNA NANOPARTICLES
D. M. Yurek et al.
NEUROSCIENCE (2015)
Focused ultrasound-mediated drug delivery through the blood-brain barrier
Alison Burgess et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice
Arne Ittner et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Resveratrol-Loaded Nanoparticles Reduce Oxidative Stress Induced by Radiation or Amyloid-β in Transgenic Caenorhabditis elegans
Haitao Yin et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2014)
Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis
George S. Bloom
JAMA NEUROLOGY (2014)
Tau protein kinases: Involvement in Alzheimer's disease
Ludovic Martin et al.
AGEING RESEARCH REVIEWS (2013)
B6 Peptide-Modified PEG-PLA Nanoparticles for Enhanced Brain Delivery of Neuroprotective Peptide
Zhongyang Liu et al.
BIOCONJUGATE CHEMISTRY (2013)
Enhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administration
Zhen-Zhen Yang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Proinflammatory Cytokines, Aging, and Age-Related Diseases
Martin Michaud et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2013)
Current and future treatments for Alzheimer's disease
Konstantina G. Yiannopoulou et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2013)
Non-transferrin bound iron in Thalassemia: Differential detection of redox active forms in children and older patients
William Breuer et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Pharmacokinetic behavior and efficiency of acetylcholinesterase inhibition in rat brain after intranasal administration of galanthamine hydrobromide loaded flexible liposomes
Weize Li et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2012)
Dendrimers reduce toxicity of Aβ 1-28 peptide during aggregation and accelerate fibril formation
Barbara Klajnert et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Amyloid Precursor Protein Processing and Alzheimer's Disease
Richard J. O'Brien et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 34 (2011)
The Role of the Blood Brain Barrier in Neurodegenerative Disorders and their Treatment
Alan M. Palmer
JOURNAL OF ALZHEIMERS DISEASE (2011)
The CD157-Integrin Partnership Controls Transendothelial Migration and Adhesion of Human Monocytes
Nicola Lo Buono et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Neurotherapeutic applications of nanoparticles in Alzheimer's disease
Jasjeet Kaur Sahni et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Immunotherapy for Alzheimer's disease
D. Morgan
JOURNAL OF INTERNAL MEDICINE (2011)
Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery
Sanju Dhawan et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2011)
Glut1/SLC2A1 Is Crucial for the Development of the Blood-Brain Barrier In Vivo
Ping-Pin Zheng et al.
ANNALS OF NEUROLOGY (2010)
RAGE-dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease
Fang Fang et al.
FASEB JOURNAL (2010)
Potential neurotoxicity of nanoparticles
Yu-Lan Hu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Apical-to-Basolateral Transport of Amyloid-beta Peptides through Blood-Brain Barrier Cells is Mediated by the Receptor for Advanced Glycation End-Products and is Restricted by P-Glycoprotein
Pietra Candela et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration
Hui Dai et al.
NANOMEDICINE (2010)
Delivery of peptide and protein drugs over the blood-brain barrier
Ivona Brasnjevic et al.
PROGRESS IN NEUROBIOLOGY (2009)
Neurobiology ofAlzheimer′s disease
E Mohandas et al.
Indian Journal of Psychiatry (2009)
CNS Delivery Via Adsorptive Transcytosis
Francoise Herve et al.
AAPS JOURNAL (2008)
Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
C. -X. Gong et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Active targeting of brain tumors using nanocarriers
Arnaud Beduneau et al.
BIOMATERIALS (2007)
Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment
D. Allan Butterfield et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Blood-brain barrier transport of therapeutics via receptor-mediation
Angela R. Jones et al.
PHARMACEUTICAL RESEARCH (2007)
The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis
S Gelperina et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
The role of inflammation in Alzheimer's disease
EE Tuppo et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Independent effects of APOE on cholesterol metabolism and brain Aβ levels in an Alzheimer disease mouse model
KM Mann et al.
HUMAN MOLECULAR GENETICS (2004)
The LPS receptor (CD14) links innate immunity with Alzheimer's disease
K Fassbender et al.
FASEB JOURNAL (2004)
The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development
AV Terry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
The metallobiology of Alzheimer's disease
AI Bush
TRENDS IN NEUROSCIENCES (2003)
Alzheimer's disease: the cholesterol connection
L Puglielli et al.
NATURE NEUROSCIENCE (2003)
Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease
AH Moore et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Amyloid-β immunotherapy for Alzheimer's disease:: the end of the beginning
D Schenk
NATURE REVIEWS NEUROSCIENCE (2002)
Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles
T Banerjee et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Lipid peroxidation and protein oxidation in Alzheimer's disease brain:: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress
DA Butterfield et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures
WH Zheng et al.
NEUROSCIENCE (2002)
Cholinergic pathology in Alzheimer's disease - discrepancies between clinical experience and pathophysiological findings
L Frolich
JOURNAL OF NEURAL TRANSMISSION (2002)
Cerebral microvascular pathology in aging and Alzheimer's disease
E Farkas et al.
PROGRESS IN NEUROBIOLOGY (2001)
分享论文
